2010PubMedRequires access

[Protective effects of Paecilomyces hepiali Cs-4 on rats with adriamycin-induced nephropathy].

Na Wang, Min Qi, Su-Ren Liang

Open publisher page 1 citations

Abstract

OBJECTIVE: To study the renal protective effect of Paecilomyces hepiali Cs-4 (Abbr. to Cs-4) on rats with adriamycin-induced nephropathy (AIN). METHODS: Twenty-four male SD rats were randomly divided into four groups: the control group (A), the model group (B), the Benazepril group (C), and the Cs-4 group (D). AIN rat model was established by left unilateral nephrectomy and repeated caudal vein injection of adriamycin. Gastric perfusion of Cs-4 [500 mg/( kg x d)] and Benazepril [4 mg/( kg x d)] was given respectively to the groups D and C, starting from 1 week after modeling. Blood biochemical indices including blood urea nitrogen (BUN), serum creatine (Scr) and 24-hour urinary protein excretion (24 h-UP) were assessed 4 and 8 weeks after medication. Rats were sacrificed at the end of 8-week medication, their renal tissue was get for pathological examination with electric microscopy, the expressions of fibronection (FN), collagen IV (COL-IV ) and osteopont (OPN) in renal tissue were assessed by immunohistochemistry. RESULTS: Levels of 24h-UP, BUN, Scr, mesengial matrix percentage, as well OPN, FN, COL-IV were significantly lower in group D than in group B (P < 0.05); and the fat metabolic disorder was improved in group D (P < 0.05). CONCLUSION: Cs-4 displays its renal protective action in rats with AIN through reducing the urinary protein excretion, correcting lipid metabolic disturbance, inhibiting the over accumulation of extracellular matrix, improving the pathological damage of kidney, thus restoring the renal function.

About this research paper

What this paper is about

OBJECTIVE: To study the renal protective effect of Paecilomyces hepiali Cs-4 (Abbr. to Cs-4) on rats with adriamycin-induced nephropathy (AIN). METHODS: Twenty-four male SD rats were randomly divided into four groups: the control group (A), the model group (B), the Benazepril group (C), and the Cs-4 group (D). AIN rat model was established by left unilateral nephrectomy and repeated caudal vein injection of adriamycin. Gastric perfusion of Cs-4 [500 mg/( kg x d)] and Benazepril [4 mg/( kg x d)] was given respectively to the groups D and C, starting from 1 week after modeling. Blood biochemical indices including blood urea nitrogen (BUN), serum creatine (Scr) and 24-hour urinary protein excretion (24 h-UP) were assessed 4 and 8 weeks after medication. Rats were sacrificed at the end of 8-week medication, their renal tissue was get for pathological examination with electric microscopy, the expressions of fibronection (FN), collagen IV (COL-IV ) and osteopont (OPN) in renal tissue were assessed by immunohistochemistry. RESULTS: Levels of 24h-UP, BUN, Scr, mesengial matrix percentage, as well OPN, FN, COL-IV were significantly lower in group D than in group B (P < 0.05); and the fat metabolic disorder was improved in group D (P < 0.05). CONCLUSION: Cs-4 displays its renal protective action in rats with AIN through reducing the urinary protein excretion, correcting lipid metabolic disturbance, inhibiting the over accumulation of extracellular matrix, improving the pathological damage of kidney, thus restoring the renal function.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE: To study the renal protective effect of Paecilomyces hepiali Cs-4 (Abbr. to Cs-4) on rats with adriamycin-induced nephropathy (AIN). METHODS: Twenty-four male SD rats were randomly divided into four groups: the control group (A), the model group (B), the Benazepril group (C), and the Cs-4 group (D). AIN rat model was established by left unilateral nephrectomy and repeated caudal vein injection of adriamycin. Gastric perfusion of Cs-4 [500 mg/( kg x d)] and Benazepril [4 mg/( kg x d)] was given respectively to the groups D and C, starting from 1 week after modeling. Blood biochemical indices including blood urea nitrogen (BUN), serum creatine (Scr) and 24-hour urinary protein excretion (24 h-UP) were assessed 4 and 8 weeks after medication. Rats were sacrificed at the end of 8-week medication, their renal tissue was get for pathological examination with electric microscopy, the expressions of fibronection (FN), collagen IV (COL-IV ) and osteopont (OPN) in renal tissue were assessed by immunohistochemistry. RESULTS: Levels of 24h-UP, BUN, Scr, mesengial matrix percentage, as well OPN, FN, COL-IV were significantly lower in group D than in group B (P < 0.05); and the fat metabolic disorder was improved in group D (P < 0.05). CONCLUSION: Cs-4 displays its renal protective action in rats with AIN through reducing the urinary protein excretion, correcting lipid metabolic disturbance, inhibiting the over accumulation of extracellular matrix, improving the pathological damage of kidney, thus restoring the renal function.

Key concepts: Benazepril, Blood urea nitrogen, Internal medicine, Endocrinology, Creatinine, Excretion, Kidney, Nephropathy

Related papers

Back to paper searchBrowse research topicsOriginal source
[Protective effects of Paecilomyces hepiali Cs-4 on rats with adriamycin-induced nephropathy]. — Research Paper | ScholarLens